Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up.
Corsini CA, Martins PFDS, Filgueiras PS, Lourenço AJ, Lima AES, Gomes SVC, Jeremias WJ, Alves PA, Fernandes GDR, Castro LLME, de Carvalho AT, Azevedo ACC, Curimbaba CAL, Lorencini DA, Junior EM, da Silva VM, Cervi MC, Borges MC, Nogueira ML, Campos GRF, Correa PRL, Carvalho TML, Dos Reis JGAC, Reis EVS, Castilho LDR, de Lima PR, do Nascimento JPR, de Oliveira JG, Filho OAM, Grenfell RFQE; Immunita team. Corsini CA, et al. Among authors: do nascimento jpr. Res Sq [Preprint]. 2024 Feb 29:rs.3.rs-3931021. doi: 10.21203/rs.3.rs-3931021/v1. Res Sq. 2024. Update in: Sci Rep. 2025 Jul 2;15(1):23040. doi: 10.1038/s41598-025-94596-9. PMID: 38464059 Free PMC article. Updated. Preprint.
Multifaceted Strategy Based on Automated Text Messaging After a Recent Heart Failure Admission: The MESSAGE-HF Randomized Clinical Trial.
Rohde LE, Rover MM, Hoffmann Filho CR, Rabelo-Silva ER, Silvestre OM, Martins SM, Passos LCS, de Figueiredo Neto JA, Danzmann LC, Silveira FS, Mesas CE, Hernandes ME, Moura LZ, Simões MV, Ritt LEF, Nishijuka FA, Bertoldi EG, Dall Orto FTC, Magedanz EH, Mourilhe-Rocha R, Fernandes-Silva MM, Ferraz AS, Schwartzmann P, de Castilho FM, Pereira Barretto AC, Dos Santos Júnior EG, Nogueira PR, Canesin M, Beck-da-Silva L, de Carvalho Silva M, Adolfi Júnior MS, Santos RHN, Ferreira A, Pereira D, López Pedraza L, Kojima FCS, Campos V, de Barros E Silva PGM, Blacher M, Cavalcanti AB, Ramires F; MESSAGE-HF Investigators. Rohde LE, et al. JAMA Cardiol. 2024 Feb 1;9(2):105-113. doi: 10.1001/jamacardio.2023.4501. JAMA Cardiol. 2024. PMID: 38055237 Free PMC article. Clinical Trial.
Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): a 12-month longitudinal study.
Corsini CA, Campos GRF, Martins PFDS, Filgueiras PS, Lima AES, Gomes SVC, Curimbaba CAL, Lorencini DA, Morandi Junior E, da Silva VM, Cervi MC, Borges MC, de Lima PR, do Nascimento JPR, Correa PRL, Castilho LDR, de Oliveira JG, Filho OAM, Nogueira ML, Grenfell RFQE. Corsini CA, et al. Among authors: do nascimento jpr. Front Immunol. 2025 Jul 15;16:1589733. doi: 10.3389/fimmu.2025.1589733. eCollection 2025. Front Immunol. 2025. PMID: 40735326 Free PMC article.
Immunogenicity and safety of CoronaVac vaccine in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up.
Corsini CA, da Silva Martins PF, Filgueiras PS, Lourenço AJ, de Souza Lima AE, Gomes SVC, de Jesus Jeremias W, Alves PA, da Rocha Fernandes G, Castro LLME, Teixeira-Carvalho A, Azevedo ACC, De Almeida Leitao Curimbaba C, Lorencini DA, Junior EM, da Silva VM, Cervi MC, de Carvalho Borges M, Nogueira ML, Campos GRF, Correa PRL, Carvalho TML, Dos Reis JGAC, de Sousa Reis EV, Dos Reis Castilho L, de Lima PR, do Nascimento JPR, de Oliveira JG, Filho OAM; Immunita Team; Grenfell RFQE. Corsini CA, et al. Among authors: do nascimento jpr. Sci Rep. 2025 Jul 2;15(1):23040. doi: 10.1038/s41598-025-94596-9. Sci Rep. 2025. PMID: 40595400 Free PMC article. Clinical Trial.